1st Quarter 2024 Earnings Release Presentation April 30, 2024 Cautionary Statements This presentation includes “forward looking statements.” These statements relate to future events, including, but not limited to, statements regarding our liquidity, operating results, future earnings, financial ...

财务数据和关键指标变化 - 第一季度净营收54亿美元,同比增长 [12] - 第一季度合并调整后EBITDA为10.2亿美元,同比增长23% [12] - 第一季度调整后EBITDA利润率为19.1% [12] 各条业务线数据和关键指标变化 USPI业务 - 第一季度USPI调整后EBITDA为3.94亿美元,同比增长16% [13][27] - USPI调整后EBITDA利润率为39.6% [27] - 同店系统收入增长6.4%,同店每例收入增长6.8% [27] - 手术量略有下降0.4% [27] 医院业务 - 第一季度医院调整后EBITDA为6.3亿美元,同比增长28% [15][28] - 医院调整后EBITDA利润率为14.4% [28] - 同院住院量增长4.2% [15][28] - 每调整后入院收入增长8.8% [15][28] 各个市场数据和关键指标变化 - 密歇根州医疗补助医院调整费用计划带来8800万美元额外收入,其中一半来自2023年第四季度 [30][35] - 除去该补助,每调整后入院收入仍增长6.1% [31] 公司战略和发展方向及行业竞争 - 公司已完成9家医院的出售,获得40亿美元现金,用于偿还债务和投资门诊业务 [9][21][22] - 公司已将杠杆率从2018年初的约7倍降至3.5倍 [22][33] - 公司将继续优先投资于USPI的并购扩张,以及医院高端专科服务的有机增长 [39] - 公司认为门诊业务和医院业务的组合更加可预测、资本效率高、利润率和自由现金流更强 [23][24] 管理层对经营环境和未来前景的评论 - 公司第一季度业绩大幅超出预期,反映了需求的持续恢复和高收入水平 [12] - 公司对2024年的需求前景保持乐观,将调高全年调整后EBITDA指引至35-37亿美元 [19][20] - 公司认为2023年的强劲增长不仅是暂时性的推迟需求,而是可持续的基本面增长 [46][47][48] 问答环节重要的提问和回答 问题1 **Kevin Fischbeck提问** USPI同店手术量增长乏力的原因及后续趋势 [44] **Saum Sutaria回答** 公司预计手术量将在全年逐步提升,2023年强劲增长并非一次性推迟需求,而是可持续的基本面增长 [45][46][47][48] 问题2 **Justin Lake提问** 第一季度业绩大幅超预期的原因,以及未来债务水平预期 [51][52][53][54] **Saum Sutaria和Sun Park回答** 第一季度USPI和医院业务的收入和利润均大幅超预期,公司将根据资本配置决定未来的具体杠杆水平 [53][54][55] 问题3 **Stephen Baxter提问** 医院业务的收入和利润率提升的驱动因素,尤其是商业保险和医疗补助业务的变化 [57][58][59][60] **Saum Sutaria回答** 医院业务的量增、收入质量提升(包括商业保险和医疗补助)以及成本管控是利润率提升的主要原因 [59][60]

For the quarter ended March 2024, Tenet Healthcare (THC) reported revenue of $5.37 billion, up 6.9% over the same period last year. EPS came in at $3.22, compared to $1.42 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $5.14 billion, representing a surprise of +4.42%. The company delivered an EPS surprise of +122.07%, with the consensus EPS estimate being $1.45.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Tenet Healthcare (THC) came out with quarterly earnings of $3.22 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 122.07%. A quarter ago, it was expected that this hospital operator would post earnings of $1.58 per share when it actually produced earnings of $2.68, delivering a surprise of 69.62%.Over the last four quarters, t ...

Exhibit 99.1 Tenet Reports First Quarter 2024 Results Well in Excess of Guidance; Raises 2024 Financial Outlook • Net income from continuing operations available to common shareholders in first quarter 2024 was $2.151 billion, or $21.38 per diluted share, including an after-tax gain of $1.856 billion, or $18.45 per diluted share, associated with previously announced hospital divestitures • Adjusted diluted earnings per share from continuing operations1 was $3.22 in first quarter 2024 • Consolidated Adjusted ...

Tenet Healthcare (THC) 财报预测 - Tenet Healthcare (THC) 预计在2024年3月季度的收入增长将带来盈利增长[1] - 公司将于2024年4月30日发布财报，如果关键数字超出预期，股价可能会上涨[2] - 分析师们对公司未来盈利前景持乐观态度，预计每股收益为$1.45，同比增长2.1%[4] - 过去30天内，关于该季度的每股收益预期已上调5.88%[5] - Zacks Earnings ESP 模型显示，根据最准确预期与Zacks共识预期的比较，Tenet 有望超出预期[8] - 过去四个季度，Tenet 四次超出共识每股收益预期[14] - 公司的 Earnings ESP 和 Zacks Rank 都表明 Tenet 有望超出共识每股收益预期[20]

THC股票走势 - THC股票在2月初至3月中旬出现上涨，尽管空头利益增加了30%，暗示其技术实力[1] - THC股票价格回落至25日均线，该均线一直支撑着股价，目前交易在100美元以上，可能是时候考虑购买看涨期权，因为我们预计这种上涨趋势将继续[2] - 周末交易者期权推荐服务的订阅者在周日晚上收到了关于THC的评论，以及详细的期权交易建议，包括完整的进出场参数[3]

Tenet Healthcare (THC) closed the most recent trading day at $102.18, moving +1.46% from the previous trading session. This change outpaced the S&P 500's 1.11% gain on the day. Meanwhile, the Dow experienced a rise of 0.8%, and the technology-dominated Nasdaq saw an increase of 1.24%.Heading into today, shares of the hospital operator had gained 2.6% over the past month, outpacing the Medical sector's loss of 2.46% and the S&P 500's gain of 0.48% in that time.Investors will be eagerly watching for the perfo ...

Shares of Tenet Healthcare Corporation (THC) have surged 75.8% in the past year compared with the industry’s 25.4% increase. The Medical sector has gained 7.2% while the S&P 500 composite index has risen 28.4% in the said time frame. With a market capitalization of $10.3 billion, the average volume of shares traded in the last three months was 1.2 million.Growing admissions and hospital surgeries, acquisitions, divestitures of facilities not core to its long-term growth and an impressive financial position ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Tenet Healthcare (THC) .Tenet currently has an average brokerage recommend ...